Material Safety Data Sheet (MSDS) for AntibodyShop unconjugated antibodies MON*.

Material According to Annex II of EC Regulation No. 1907/2006 concerning REACH

Early diagnosis of AKI currently depends on detection of reduced kidney function by the rise in serum creatinine concentration, an unreliable measure in the acute setting. This article discusses the pros and cons of emerging early biomarkers which may prove useful.

Dr. Lars Otto Uttenthal, Scientific Director of BioPorto Diagnostics, presented the latest data on the new biomarker APC-PCI in Granada, Spain, last November 21, 2008.

The anorectic gut hormones GLP-1 (glucagon-like peptide 1) and co-secreted peptides such as oxyntomodulin and PYY are among prime candidates for manipulation in the development of new therapies for obesity. Here their secretion and actions in pathways regulating food intake are briefly outlined.